Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01061320
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 200 participants
- Sponsor
- Thammasat University
- Registry
-
NCT01061320
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Thailand
- Registry status
- Unknown status
Technical summary
Registry record NCT01061320. Randomized; double masking; primary purpose prevention. Start 2010-01 (registry gives no type); primary completion 2010-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
- Condition
- Contrast Induced Nephropathy
- Intervention (Drug)
- alpha tocopherol
- Intervention (Drug)
- placebo
- Lead sponsor
- Thammasat University
Record details
- Record id
cardio:ct-nct01061320- Content hash
c2e913f4c9762838f657089694a74424fafa3c6bb74b9c2fe2f4249dc4047262